The outlook of companies tied to blockbuster drugs like Viagra presents a complex investment landscape . While the initial boom of copyright, fueled by Viagra's remarkable popularity, generated substantial returns, the loss of exclusivity in key territories has introduced substantial volatility. Investors are now grappling with the impact of rival